Latest News and Press Releases

PORTOLA VALLEY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a national nonprofit and leading sponsor of tick-borne disease research in the US, today announced publication of...

Action immédiate contre l’arthrite réunit 21 organisations, plus de 100  000 patients, des chercheurs, des cliniciens et des défenseurs de la cause afin de transformer la recherche sur l’arthrite et...

Arthritis Action Now unites 21 organizations, more than 100,000 patients, researchers, clinicians and advocates to transform arthritis research and care in Canada TORONTO, April 08, 2026 (GLOBE...

Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204

ROCHESTER, NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec” or the “Company”), a leading provider of technology across defense, biomedical,...

NETANYA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) today announced that it has entered into an option agreement to acquire control of DFSL, a developer of...

Gigamon is recognized as the leading vendor in the deep observability market with 51 percent market share in 2025 by 650 Group.

ROCHESTER, NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of technology products to defense,...

New research from Momentive Software finds growth path visibility and technology efficiency are critical to workforce stability in mission-driven sector.

Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204